Skip to content

A Multi-Modal Deep Learning Framework with Both Sequence and Structure for Tumor Antigens Prediction

Nov 2024 · bioRxiv · 2 citations
Biology

TL;DR

A pioneering multi-modal framework with TCR-peptide-HLA sequence and structure features incorporating an attention mechanism designed to accurately identify tumor antigens with immunogenic properties, which presents a brand-new and promising approach for cancer immunotherapies that target tumor antigens.

Read PDF

Similar papers

Open access Jul 2026

ImmunoFoundation: A Multimodal Deep Learning Approach to Immunogenicity Prediction 2310036

The ImmunoFoundation Model (IFM), a multimodal deep learning system that integrates not only peptide sequences, 3D molecular structures, and biochemical properties but also TCR-MHC-peptide to achieve superior immunogenicity prediction and enable peptide optimization for therapeutic applications is developed.

Smita Krishnaswamy, J. Rocha, Hiren Madhu et al. · 0 citations
#small language model Open access Aug 2026

Using multimodal foundational models to predict neoantigen immunogenicity and vaccine effectiveness across different tumor types

This work is the first to use a multi-modal foundation model for neoantigen vaccines, overcoming the tumor-type-specific constraints of conventional approaches and facilitating joint modelling of immunogenicity and clinical efficacy, thereby offering an AI decision engine for precision cancer vaccine design that is app...

Gang Liu, Jia Wang, Jia Zhu · 2 citations
Review Open access Jul 2026

Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction

The current role of AI is summarized across the peptide cancer vaccine development pipeline, from neoantigen discovery and epitope prioritization to prediction of peptide–HLA binding, antigen presentation, and T-cell receptor recognition, and the application of modern computational frameworks.

P. Brlek, J. Kolić, L. Bulić et al. · 0 citations
Jul 2026

Antigen-specific Antibody Multi-modal Foundation Model for Functional Antibody Design

AAMFM, an Antigen-specific Antibody Multimodal Foundation Model that learns unified representations of antibody sequences and structures conditioned on antigen context, achieves state-of-the-art performance in functional antibody design, revealing its potential for antigen-specific antibody engineering.

Xiaoliang Shi, Zichen Wang, Runze Ma et al. · 0 citations
Sep 2026

NeoGen-BC: A synergistic framework combining generative protein language models and multi-window deep learning for designing shared neoantigens in breast cancer.

Breast cancer, particularly hormone receptor-positive (HR+) and triple-negative (TNBC) subtypes, is often immunologically "cold," limiting immunotherapy efficacy. Neoantigen-based vaccines hold promise but face challenges from inaccurate identification and overreliance on HLA binding affinity, which poorly captures tru...

Van-The Le, Juan Peter Timothy Yuune, Jiun-I Lai et al. · 0 citations
Sep 2026

Deciphering T-cell receptor-antigen recognition through interpretable residue-level interaction modeling.

Evaluation across multiple settings indicates that TCR-IFNet achieves competitive performance compared with existing methods, with higher AUPRC observed on both antigen-specific and healthy-sourced datasets, as well as improved results on independent test sets.

Wen-Yu Xi, Ru-Heng Wang, Xiu-Cai Ye et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.